Canopy Growth Correlations
CGC Stock | USD 1.11 0.02 1.77% |
The current 90-days correlation between Canopy Growth Corp and Cannae Holdings is 0.34 (i.e., Weak diversification). The correlation of Canopy Growth is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Canopy Growth Correlation With Market
Modest diversification
The correlation between Canopy Growth Corp and DJI is 0.29 (i.e., Modest diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Canopy Growth Corp and DJI in the same portfolio, assuming nothing else is changed.
Canopy |
Moving together with Canopy Stock
0.83 | CDIOW | Cardio Diagnostics | PairCorr |
0.87 | VINC | Vincerx Pharma Earnings Call This Week | PairCorr |
0.64 | ELEV | Elevation Oncology | PairCorr |
0.85 | ELVN | Enliven Therapeutics | PairCorr |
0.84 | GPCR | Structure Therapeutics | PairCorr |
0.94 | ZURA | Zura Bio Limited | PairCorr |
0.88 | IMMX | Immix Biopharma | PairCorr |
0.76 | IMRX | Immuneering Corp | PairCorr |
0.94 | MLTX | MoonLake Immunotherapeuti | PairCorr |
0.87 | PMVP | Pmv Pharmaceuticals | PairCorr |
0.93 | PYXS | Pyxis Oncology | PairCorr |
0.86 | SCLX | Scilex Holding | PairCorr |
0.9 | ASMB | Assembly Biosciences Earnings Call This Week | PairCorr |
0.8 | ATNF | 180 Life Sciences | PairCorr |
0.65 | AVTE | Aerovate Therapeutics | PairCorr |
0.61 | BIIB | Biogen Inc | PairCorr |
Moving against Canopy Stock
0.94 | SNY | Sanofi ADR | PairCorr |
0.92 | AZN | AstraZeneca PLC ADR | PairCorr |
0.89 | GILD | Gilead Sciences | PairCorr |
0.78 | OCX | OncoCyte Corp | PairCorr |
0.77 | GOSS | Gossamer Bio | PairCorr |
0.64 | LLY | Eli Lilly | PairCorr |
0.61 | BMY | Bristol Myers Squibb | PairCorr |
0.55 | PLX | Protalix Biotherapeutics | PairCorr |
0.92 | AMGN | Amgen Inc | PairCorr |
0.77 | DRMAW | Dermata Therapeutics | PairCorr |
0.77 | NVCT | Nuvectis Pharma | PairCorr |
0.54 | CMPX | Compass Therapeutics | PairCorr |
0.4 | RVP | Retractable Technologies Earnings Call This Week | PairCorr |
Related Correlations Analysis
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Canopy Stock performing well and Canopy Growth Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Canopy Growth's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
PTLO | 2.93 | 0.52 | 0.16 | 0.32 | 2.90 | 8.12 | 22.46 | |||
CNNE | 1.39 | (0.03) | 0.00 | (0.10) | 0.00 | 2.60 | 7.93 | |||
PINS | 2.13 | 0.19 | 0.08 | 0.15 | 2.35 | 5.04 | 26.52 | |||
WEN | 1.21 | (0.13) | 0.00 | (0.62) | 0.00 | 3.46 | 7.39 | |||
SOGP | 4.30 | 0.49 | 0.11 | 1.01 | 4.42 | 12.90 | 38.53 | |||
ARKR | 3.12 | (0.32) | 0.00 | (0.53) | 0.00 | 4.61 | 24.40 | |||
IRDM | 1.75 | (0.01) | 0.00 | (0.07) | 0.00 | 2.69 | 22.16 |
Canopy Growth Corporate Management
Mark Ware | Chief Medical Officer | Profile | |
Terry Yanofsky | Director | Profile | |
FCPA FCA | Strategic Advisor | Profile | |
Robert Hanson | Independent Director | Profile |